Biotechnology Market Research Reports

Global Sequencing Market By Product (Consumables, Instruments, and Services), By Application (Oncology, Clinical Diagnostics, Agrigenomics, Forensics, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Hospitals & Clinics, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Sequencing Market was valued at US$ 17.3 Billion in 2024 and is expected to grow at a CAGR of 21.4% from 2024 to 2034. In 2024, North America led the market, a...
- ★★★★★
  
  ★★★★★
  
  (142)
- April 2025
- Pages: 326
- US $3,999 Onwards
- Formats:
Global Gene Synthesis Service Market By Method (Solid-phase Synthesis, Chip-based Synthesis, and PCR-based Enzyme Synthesis), By Services (Antibody DNA Synthesis, Viral DNA Synthesis, and Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, and Others), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Gene Synthesis Service Market size is expected to be worth around US$ 16 Billion by 2034, from US$ 2.1 Billion in 2024, growing at a CAGR of 22.5% during t...
- ★★★★★
  
  ★★★★★
  
  (142)
- April 2025
- Pages: 398
- US $3,999 Onwards
- Formats:
Global Cell And Gene Therapy Manufacturing Market By Therapy Type (Cell therapy, Gene therapy) By Mode (In-house Manufacturing, Contract Manufacturing (CDMOs & CMOs)) By Scale (Preclinical and Clinical-Scale, Commercial-Scale) By Application (Oncology (Cancer Treatment), Neurological Disorders, Cardiovascular Diseases, Rare & Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications) By End-user (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs/CMOs), Research Institutes & Academic Organizations, Hospitals & Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2025-2034

Report Overview Global Cell And Gene Therapy Manufacturing Market size is expected to be worth around US$ 60.3 Billion by 2034 from US$ 6.9 Billion in 2024, growing at a CAGR of 24.3...
- ★★★★★
  
  ★★★★★
  
  (142)
- April 2025
- Pages: 394
- US $3,999 Onwards
- Formats:
Global Blood Based Biomarkers Market Analysis By Type (Diagnostic, Predictive, Prognostic, Therapeutic), By End Use (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Blood Based Biomarkers Market size is expected to be worth around US$ 63.9 Billion by 2034, from US$ 20.4 Billion in 2024, growing at a CAGR of 12.1% durin...
- ★★★★★
  
  ★★★★★
  
  (142)
- April 2025
- Pages: 377
- US $3,999 Onwards
- Formats:
Global Upstream Bioprocessing Market By Product Type (Bioreactors/Fermenters, Cell Culture Products, Filters, and Others), By Technology (Multi-use and Single-use), By Application (Media Preparation, Cell Culture, and Cell Separation), By Mode (In-house and Outsourced), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Upstream Bioprocessing Market size is expected to be worth around US$ 102.1 billion by 2034 from US$ 26.6 billion in 2024, growing at a CAGR of 14.4% durin...
- ★★★★★
  
  ★★★★★
  
  (142)
- April 2025
- Pages: 254
- US $3,999 Onwards
- Formats:
Latin America Monoclonal Antibodies For Cancer Market Product Type (Bevacizumab, Cetumaximab, Ipilimumab, Nivolumab, Pembrolizumab, Pertuzumab, Rituximab, Trastuzumab Trastuzumab and Emtansine), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Blood Cancer, Melanoma, Liver Cancer and Others), Source (Humanized mAb, Human mAb and Chimeric mAb), End-User (Hospitals, Research Institutes and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Latin America Monoclonal Antibodies For Cancer Market size is expected to be worth around US$ 16.6 Billion by 2034 from US$ 5.8 Billion in 2024, growing at a CAGR...
- ★★★★★
  
  ★★★★★
  
  (142)
- April 2025
- Pages: 227
- US $3,999 Onwards
- Formats:

« Previous 1 … 15 16 17 18 19 … 32 Next »